Abstract
Suboccipital decompression with duraplasty is a widely accepted method for treating patients with Chiari malformation type I. However, important details of the duraplasty technique are still controversial. This retrospective study analyzes clinical and radiological outcomes after surgery depending upon the type of graft and methods of graft fixation. Seventy consecutive decompressions with duraplasty were analyzed. Two types of grafts, nonautologous (Non-AutoG; 60.0%) and autologous (AutoG; 40.0%), and two methods of graft fixation, suturing (S; 67.1%) and gluing (G; 32.9%), were used in four different combinations: (Non-AutoG+S: 31.4%; Non-AutoG+G: 28.6%; AutoG+S: 35.7%; AutoG+G: 4.3%) according to surgeon preference. The mean follow-up was 63.4 months. According to gestalt and Chicago Chiari Outcome Scales, satisfactory results were obtained in 72.9% and 78.6% of cases, respectively, in the long term. The outcomes were not related to the kind of graft (p = 0.44), fixation method (p = 0.89) or duraplasty pattern (p = 0.32). Decreased syringomyelia was observed in 88.9% of cases, and no associations with the kind of graft (p = 0.84), fixation method (p = 1) or duraplasty pattern were found (p = 0.96). Pseudomeningocele occurred 5 times more often in the Non-AutoG group than in the AutoG group (52.4% vs. 10.7%; p < 0.05), whereas their formations were not related to the fixation method (p = 0.34). Three cases (12.0%) required reoperation with reduraplasty. Autologous and nonautologous dural grafts can be sutured or glued with similar clinical results; however, the use of nonautologous grafts is linked with a much higher risk of pseudomeningocele formation.
Subject terms: Diseases, Outcomes research, Neurological disorders
Introduction
Chiari malformation (CM) was described for the first time by pathologist Hans Chiari in 1891 and refers to congenital caudal displacement of the hindbrain elements through the foramen magnum. The prevalence of CM is estimated as ranging from 0.24 to 3.6% of the population with a slight female predominance1–3. The treatment of choice in symptomatic cases is posterior fossa decompression, described for the first time in 1938 by Penfield4. This procedure has changed and improved over the years. Suboccipital craniectomy with C1 or even C2 laminectomy and duraplasty is currently a widely accepted and recommended method for treating patients with CM5.
Different kinds of material are used for duraplasty, including autologous tissues such as epicranial aponeurosis or muscle fascia and nonautologous (synthetic) materials such as bovine collagen matrix6–8. Details of the surgery, especially concerning the duraplasty techniques, are still the subject of debate9–12. However, to our knowledge, there has been no study evaluating the kind of graft used for duraplasty along with the method of its fixation. The aim of our study was to compare the long-term clinical and radiological outcomes of surgery for CM-I, together with a complication analysis, depending upon the duraplasty materials and methods of graft fixation.
Materials and methods
Ninety patients with symptomatic Chiari malformation type I (CM-I) underwent posterior fossa decompression (PFD) with duraplasty from January 2003 to December 2018. Twenty patients were lost to radiological follow-up and were excluded from the study. Finally, 70 patients were included. The whole group involved 54 women and 16 men, ranging in age from 18 to 66 years (average 41.9 years old). The average duration of symptoms was 67.3 months (range: 3 months–50 years). The main reasons for diagnosis were suboccipital or general headache (68.6%) (Table 1). The mean follow-up was time 63.4 months (range 3–187 months).
Table 1.
Preoperative signs and symptoms in 70 patients with symptomatic Chiari malformation type I.
| Signs and symptoms | Number of patients (%) |
|---|---|
| Suboccipital or general headache | 48 (68.6%) |
| Neck and back pain | 45 (64.3%) |
| Shoulder and arm pain | 28 (40.0%) |
| Decreased temperature sensitivity | 32 (45.7%) |
| Decreased touch sense | 22 (31.4%) |
| Decreased proprioceptive sense | 3 (4.3%) |
| Decreased pain sensitivity | 25 (35.7%) |
| Somatosensory disturbances (paresthesia, hyperesthesia) | 37 (52.9%) |
| Paresis or motor weakness | 30 (42.9%) |
| Cerebellar signs (nystagmus, ataxia, dizziness, dysarthria, imbalance) | 28 (40.0%) |
| Dysphagia | 15 (21.4%) |
| Visual disturbance | 3 (4.3%) |
| Sleep apnea | 0 (0.0%) |
| One-sided signs or symptoms | 23 (32.9%) |
| Both-sided signs or symptoms | 34 (48.6%) |
| Non-specified | 13 (18.6%) |
All patients underwent suboccipital craniectomy with C1 posterior arch removal. Partial or whole C2 laminectomy was additionally performed in 24 (34.3%) and 6 (8.6%) patients, respectively. The range of cervical bony decompression depended upon the level of tonsil descent.
Two types of grafts were used: nonautologous (Non-AutoG) in 42 patients (60.0%) and autologous (AutoG) in 28 cases (40.0%). Non-AutoG included Duragen Integra (22), Duragen Plus Integra (12), Durepair Medtronic (8) and AutoG included fascia lata (4) or pericranium (24).
The grafts were fixed in two ways: with sutures (S) in 47 (67.1%) cases or with fibrin glue (G) only in 23 (32.9%) cases. Therefore, 4 different patterns of duraplasty were distinguished: (1) nonautologous graft fixed with sutures (Non-AutoG+S; 31.4%), (2) nonautologous graft fixed with glue (Non-AutoG+G; 28.6%), (3) autologous graft fixed with sutures (AutoG+S; 35.7%), and 4. autologous graft fixed with glue (AutoG+G; 4.3%). The extent of decompression depended upon the level of tonsil descent, but the duraplasty technique was related to surgeon preference. Patients were operated on using a consistent surgical technique, i.e., without opening the arachnoid and 4th ventricle or tonsil resection (see Fig. 1).
Figure 1.
Intraoperative photographs showing two of the four duroplasty patterns described in article. (A) Bony decompression, Y-shaped incision of the dura with arachnoid membrane intact. (B) Autologous graft (pericranium) sutured in a watertight fashion (AutoG+S). (C,D) Nonautologous graft (Duragen) fixed with fibrin glue only (Non-AutoG+G).
Patients were divided into groups depending on surgical technique and the presence of pseudomeningocele on follow-up MRI. Long-term clinical outcomes were evaluated with gestalt assessment (improvement, unchanged or deterioration) and the Chicago Chiari Outcome Score (CCOS, range 4–16 score)13,14. Based on gestalt, we divided patients into satisfactory (improvement and unchanged) and unsatisfactory (deterioration) groups. Similarly, using the CCOS, the patients were assigned to the satisfactory (≥ 12 score) or unsatisfactory (< 12 score) group. The size of the syrinx cavity was compared to that on preoperative MRI and evaluated as decreased, stable or increased. All complications requiring separate management were recorded and analyzed as potentially dependent upon the duraplasty technique. In follow-up MRI, the presence and average maximal thickness of pseudomeningoceles was evaluated within each duraplasty group.
According to the statement of Bioethics Committee of Medical University of Warsaw this study did not require IRB/ethics committee approval and patient consent. All methods were carried out in accordance with relevant guidelines and regulations.
Statistical analysis
The aligned rank transform tool (ARTool package) for nonparametric factorial ANOVAs in the R environment was used with a group factor and time factor. Differences between more than two groups were analyzed using Kruskal–Wallis one-way analysis of variance with the Dwass-Steel-Critchlow-Fligner test and Benjamini and Hochberg adjustment of the p value for post hoc tests. Qualitative variables were analyzed using the chi-squared test with appropriate correction applied15,16.
Results
The mean preoperative symptom duration in the Non-AutoG, AutoG, S and G groups was 67.5, 67.1, 73.4 and 54.7 months, respectively (Non-AutoG vs. AutoG: p = 0.23; S vs. G: p = 0.11). The mean symptom durations in the Non-AutoG+S, Non-AutoG+G, AutoG+S and AutoG+G groups were as follows: 79.6, 53.3, 68.0 and 64.0 months (p = 0.11).
Based on gestalt and CCOS in the whole cohort, satisfactory results were obtained in 72.9% and 78.6% of patients, respectively (mean CCOS 12.34; SD ± 2.41). Satisfactory outcomes on the gestalt scale were observed in 76.2% of the non-AutoG group and in 67.9% of the AutoG group (p = 0.44). The rates of satisfactory CCOS (≥ 12) were identical in the Non-AutoG and AutoG groups (78.6%, p = 1). We observed long-term occipital pain exacerbation in 25.0% of the AutoG group when the autograft was harvested from the same incision and in 9.5% in the Non-AutoG group (p = 0.09).
Considering only the method of graft fixation, satisfactory results based on gestalt and CCOS were observed in 72.3% and 80.9% of the S group and 73.9% and 78.3% of the G group (p = 0.89, p = 0.79), respectively (Table 2).
Table 2.
Long-term follow-up in Chicago Chiari Outcome Scores (CCOSs) depend on kind of grafts and methods of graft fixation.
| CCOS (total score) | 16 (excellent outcome) | 15-12 (functional outcome) | 11-8 (impaired outcome) | 7-4 (incapacitated outcome) |
|---|---|---|---|---|
| Non-AutoGa | 0 (0.0%) | 33 (78.5%) | 7 (16.7%) | 2 (4.8%) |
| AutoGb | 2 (7.1%) | 20 (71.4%) | 5 (17.9%) | 1 (3.6%) |
| Sc | 2 (4.3%) | 34 (72.3%) | 9 (19.1%) | 2 (4.3%) |
| Gd | 0 (0.0%) | 18 (78.3%) | 4 (17.4%) | 1 (4.3%) |
1Non-autologous graft, 2Autologous graft, 3Graft fixed with sutures, 4Graft fixed with glue.
In the Non-AutoG+G group, 80.0% of patients improved or remained unchanged, and 80.0% achieved a satisfactory CCOS. In the AutoG+S group, satisfactory results on the gestalt and CCOS scales were observed in 76.0% and 80.0%, respectively. In the Non-AutoG+S group, satisfactory gestalt and CCOS results were observed in 72.7% and 77.3%, respectively. In the AutoG+G group, 2 out of 3 patients deteriorated on the gestalt scale and had unsatisfactory outcomes in terms of the CCOS.
Fifty-four (77.1%) patients presented with syringomyelia. After surgery, the syrinx length decreased in 88.2% of the Non-AutoG group and in 90.0% of the AutoG group. Regarding the method of graft fixation, the syringomyelia decreased in 88.9% of the S group and 88.9% of the G group (Table 3). The cross-sectional area of the syrinx decreased to a similar extent regardless of the type of graft (p = 0.82) or the method of its fixation (p = 0.78). The mean length of syringomyelia decreased in a similar range (< 2 segments) depending on graft type (p = 0.69) and method of graft fixation (p = 0.44). The syrinx increased in 2 (3.7%) cases on follow-up MRI; both were in the Non-AutoG+S group (9.1%) (Table 4).
Table 3.
Follow-up summary of clinical and radiological outcomes stratified by the type of grafts used, graft fixation methods and duraplasty materials during decompression surgery in patients with Chiari I malformation.
| Kind of grafts, methods of graft fixation and duraplasty pattern | Number of patients | Long-term results | Syringo-myelia present (pre-op) 54/70 (77.1%) | Syringomyelia on follow-up MRI Number of patients (%) |
Complication rate | Pseudomeningocele | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Improvement or unchanged | Deterioration | p | CCOS ≥ 12 | CCOS < 12 | p | Decreased 48/54 (88.9%) | Stable 4/54 (74%) or increased 2/54 (3.7%) | p | [−] | [+] | p | [+] | [−] | p | Average maximal thicknessa [SD] | p | |||
| Non-AutoG1 | 42 (60.0%) | 32 (76.2%) | 10 (23.8%) | 0.44 | 33 (78.6%) | 9 (21.4%) | 1 | 34 (80.9%) | 30 (88.2%) | 4 (11.8%) | 0.84 | 38 (90.5%) | 4 (9.5%) | 0.80 | 22 (52.4%) | 20 (47.6%) | < 0.05 | 4.62 (± 5.7) | < 0.05 |
| AutoG2 | 28 (40.0%) | 19 (67.9%) | 9 (32.1%) | 22 (78.6%) | 6 (21.4%) | 20 (71.4%) | 18 (90.0%) | 2 (10.0%) | 25 89.3%) | 3 (10.7%) | 3 (10.7%) | 25 (89.3%) | 0.61 (± 2.1) | ||||||
| S3 | 47 (67.1%) | 34 (72.3%) | 13 (27.7%) | 0.89 | 38 (80.9%) | 9 (19.1%) | 0.79 | 36 (76.6%) | 32 (88.9%) | 4 (11.1%) | 1 | 43 (91.5%) | 4 (8.5%) | 0.87 | 15 (31.9%) | 32 (68.1%) | 0.34 | 2.40 (± 4.4) | 0.24 |
| G4 | 23 (32.9%) | 17 (73.9%) | 6 (26.1%) | 18 (78.3%) | 5 (21.7%) | 18 (78.3%) | 16 (88.9%) | 2 (11.1%) | 20 (87.0%) | 3 (13.0%) | 10 (43.5%) | 13 (56.5%) | 4.26 (± 5.9) | ||||||
| Non-AutoG+S5 | 22 (31.4%) | 16 (72.7%) | 6 (27.3%) | 0.39 | 17 (77.3%) | 5 (22.7%) | 0.32 | 18 (81.8%) | 16 (88.9%) | 2 (11.1%) | 0.96 | 22 (100.0%) | 0 (0.0%) | 0.16 | 12 (54.5%) | 10 (45.5%) | < 0.05 | 4.36 (± 5.4) | < 0.05 |
| Non-AutoG+G6 | 20 (28.6%) | 16 (80.0%) | 4 (20.0%) | 16 (80.0%) | 4 (20.0%) | 16 (80.0%) | 14 (87.5%) | 2 (12.5%) | 16 (80.0%) | 4 (20.0%) | 10 (50.0%) | 10 (50.0%) | 4.9 (± 6.1) | ||||||
| AutoG+S7 | 25 (35.7%) | 19 (76.0%) | 6 (24.0%) | 20 (80.0%) | 5 (20.0%) | 18 (72.0%) | 16 (88.9%) | 2 (11.1%) | 22 (88.0%) | 3 (12.0%) | 3 (12.0%) | 22 (88.0%) | 0.68 (± 2.2) | ||||||
| AutoG+G8 | 3 (4.3%) | 1 (33.3%) | 2 (66.7%) | 1 (33.3%) | 2 (66.7%) | 2 (66.7%) | 2 (100.0%) | 0 (0.0%) | 3 (100.0%) | 0 (0.0%) | 0 (0.0%) | 3 (100.0%) | 0.0 (± 0.0) | ||||||
1Nonautologous graft, 2Autologous graft, 3Graft fixed with sutures, 4Graft fixed with glue only, 5Nonautologous graft fixed with sutures, 6Nonautologous graft fixed with glue only, 7Autologous graft fixed with sutures, 8Autologous graft fixed with glue only.
aMaximal perpendicular distance to graft measured on sagittal T2 MRI images (mm).
Table 4.
Evolving syringomyelia on follow-up MRI depends on the kind of grafts and methods of graft fixation.
| Graft and methods of graft fixation | Mean decrease in size of syringomyelia | |||
|---|---|---|---|---|
| Length -number of spinal segments (SD) | p | Cross-section area mm2 (SD) | p | |
| Non-AutoGa | 1.7 (± 2.99) | 0.69 | 32.0 (± 44.31) | 0.82 |
| AutoGb | 1.4 (± 3.18) | 29.7 (± 35.11) | ||
| Sc | 1.8 (± 3.06) | 0.44 | 30.1 (± 35.10) | 0.78 |
| Gd | 1.2 (± 3.06) | 33.0 (± 50.93) | ||
1Non-autologous graft, 2Autologous graft, 3Graft fixed with sutures, 4Graft fixed with glue.
Pseudomeningocele was present in 25 (35.7%) cases on follow-up MRI; however, it occurred significantly more frequently in the Non-AutoG group than in the AutoG group (52.4% vs. 10.7%; p < 0.05). Additionally, the rate of pseudomeningocele was similar in the G group compared with the S group (43.5% vs. 31.9%; p = 0.34). The rates of pseudomeningocele were 54.5%, 50.0%, and 12.0% in the Non-AutoG+S, Non-AutoG+G, and AutoG+S groups, respectively, and there were none in the AutoG+G group (p < 0.05). Correlations between duroplasty features and average thickness of pseudomeningocele are presented in Table 3.
Seven (10.0%) patients had postoperative complications: 4 (9.5%) in the Non-AutoG group and 3 (10.7%) in the AutoG group (p = 1, see Table S1 in supplementary material). Five (7.1%) patients needed revision surgery, and 2 were conservatively treated for aseptic meningitis (1 patient, Non-AutoG) and purulent cutaneous fistula (1 patient, AutoG). In the Non-AutoG group, 3 (7.1%) patients were reoperated on for cerebellar subsidence, of whom 2 (4.8%) also had large pseudomeningocele and 2 (4.8%) had acute hydrocephalus. In all patients with complications in the Non-AutoG group, the graft was fixed with glue (Non-AutoG+G). In the AutoG group, two patients (7.1%) required revision surgery: 1 (3.6%) for symptomatic extradural hematoma and 1 (3.6%) for symptomatic pseudomeningocele. All patients with complications in the AutoG group had the graft fixed with sutures (AutoG+S, Tables 3 and 5).
Table 5.
Postoperative complications.
| Complications | Numbera (%) | Duraplasty pattern (number) |
|---|---|---|
| Extradural hematoma | 1 (1.4%) | AutoG+S (1) |
| Symptomatic pseudomeningocele | 3 (4.3%) |
Non-AutoG+G (2) AutoG+S (1) |
| Aseptic meningitis | 1 (1.4%) | Non-AutoG+G (1) |
| Cerebellar subsidence | 3 (4.3%) | Non-AutoG+G (3) |
| Acute hydrocephalus | 2 (2.9%) | Non-AutoG+G (2) |
| Purulent cutaneous fistula | 1 (4.3%) | AutoG+S (1) |
aSeven (10%) patients had postoperative complications, with multiple adverse events in 3 of them: 1. cerebellar subsidence and large pseudomeningocele and acute hydrocephalus, 2. cerebellar subsidence and acute hydrocephalus, 3. cerebellar subsidence and large pseudomeningocele.
The risk of surgical revision for pseudomeningocele in the Non-AutoG, AutoG, S and G groups was 4.8%, 3.6%, 2.1% and 8.7%, respectively (Non-AutoG vs. AutoG: p = 0.81; S vs. G: p = 0.2). In the Non-AutoG+S, Non-AutoG+G, AutoG+S and AutoG+G groups, the risk of surgical revision was 0, 10.0%, 4.0% and 0, respectively (p = 0.34).
Three patients with pseudomeningocele underwent repeat duraplasty with suturing of the graft. All 3 cases of cerebellar subsidence were treated by resection of one cerebellar tonsil and by optimization of craniectomy size with the use of an artificial bone flap. One patient with acute hydrocephalus was treated with a ventriculoperitoneal shunt. Among patients with postoperative complications, the mean long-term CCOS score was 8.25 (SD ± 2.28) in the Non-AutoG group and 8.67 (SD ± 2.87) in the AutoG group.
Discussion
For duraplasty, many autologous or nonautologous kinds of grafts have been described in the literature7,10,17–20. Furthermore, methods of graft fixation include suturing with running or single stiches or sealing with fibrin glue7,21,22. Klekamp reported an overall 73.6% clinical improvement in patients after posterior fossa decompression with duraplasty, in short-term follow-up regardless of whether autologous or nonautologous graft was used. Concurrently, he noted high neurological deterioration in long-term observation: 14.3% within 5 years and 15.4% within 10 years, with a significantly higher rate of symptom recurrence when the autologous graft was used23.
The average rate of syrinx cavity decrease after surgical decompression ranges between 76.1 and 81.1%12,23–25. Attenello et al. observed substantially better syrinx improvement in patients with nonautologous grafts (80.0%) than in patients with pericranial autografts (52.0%)17.
In our series, regardless of what kind of graft was used and how it was fixed, the clinical outcomes and effect on syrinx was very similar after a mean 5.3 years of follow-up. However, the AutoG+G subgroup was too small for reliable statistical comparisons (Table 3).
Pseudomeningocele formation was five times more frequent in our series when a nonautologous graft was used (52.4% vs. 10.7%, p < 0.05) and its mean maximal thickness was larger in the Non-AutoG group (4.62 mm vs. 0.61 mm, p < 0.05). Attenello et al. demonstrated a similar observation (pseudomeningocele occurrence: 24.0% vs. 11.0%)17.
Unexpectedly, of the method of graft fixation played a smaller role in our series than the type of graft. The risk of pseudomeningocele formation was 43.5% when the graft was fixed with glue and 31.9% in the when the graft was fixed with suturing (p > 0.05).
Most of the pseudomeningoceles were small, asymptomatic fluid spaces filling the dead extradural space, with no mass effect on the intradural structures and no subsequent healing problems or external CSF leaks. For greater accuracy in our study, we assessed every visible CSF collection above-graft on the MRI study, even if small (min. 2 mm of thickness), in order to verify their exact significance. However, they may cause psychological discomfort to the patients26. On the other hand, artificial grafts may present less potential to form strong adhesions with surrounding tissues on extra- and intradural side. This could explain why pseudomeningocele is more frequent and why some authors report better clinical outcomes with the use of artificial grafts17,23.
The most common complications reported in the literature were aseptic meningitis (4–32%), CSF leak (6–21%), and wound infection (0.5–7%)5,23,24,27. Some materials seem to predispose patients to specific complications, such as nonautologous grafts to aseptic meningitis and bacterial infections10,27. In our series, in the Non-AutoG group, one (2.4%) patient had aseptic meningitis, and in the AutoG group, one (3.6%) had a purulent cutaneous fistula. Vanaclocha observed CSF leakage in 15.0% of cases after duraplasty with a nonautologous graft (polytetrafluoroethylene) and none after pericranium usage20. Opposite results were reported by Klekamp and Attenello et al. observed with a higher rate of CSF leak after duraplasty with pericranium17,23. Observations similar to ours were reported by Yahanda et al. in a recent multi-center study where autografts and nonautologous grafts had a comparable complication rate (p = 0.12), with higher rates of pseudomeningocele (p = 0.04) related to the use of the nonautologous graft. However, methods of graft fixation were not evaluated and, unlike our adult cohort, concerned pediatric patients, which may have influenced the wound healing process28.
Complications occurred in 2 of our 4 duraplasty pattern groups, with no complications among the Non-AutoG+S and AutoG+G groups. However, differences in complication rates between the groups were statistically insignificant (Table 3). The highest complication rate was in the Non-AutoG+G group (20.0%); however, in 3 (15.0%) cases, the main indication for surgical revision was symptomatic cerebellar subsidence, which was due to an oversized craniectomy, rather than the duraplasty pattern. In general, neither the type of graft nor the method of its fixation were significantly associated with the risk and type of complications in our series.
To harvest the pericranium, an extension of the surgical approach is required, resulting in an increased risk of abnormal wound healing, such as infection or scar dehiscence, and cosmetic complications10. If the fascia lata is harvested, the scar on the thigh carries a potential risk of incisional muscle hernia and donor site hematoma; additionally, it could be cosmetically relevant because most patients are women. Abla et al. who compared autologous and non-autologous grafts, pointed out the lack of consensus regarding what kind of graft should be used; however, they recommend using pericranium if available in good condition10. The technique of pericranium harvesting without significant extension of the primary incision was described by Stevens et al.29 Vanaclocha et al. also advised the use of pericranium and described the disadvantages of other autologous grafts, such as ligamentous weakness of the neck after nuchal ligament harvesting20. In our opinion, each additional dissection in the proximity of the site of decompression creates a greater potential space for pseudomeningocele or hematoma formation. Non-autologous grafts have some advantages such as the ease of tailoring and reduction of operative time. Disadvantages are price, a higher risk of aseptic meningitis and pseudomeningocele formation.
Although pseudomeningocele occurred five times more frequently in our Non-AutoG group, it did not result in worse clinical results. On the other hand, we noted long-term occipitalgia worsening in every fourth patient after the use of their own pericranial flap. Harvesting of the pericranium may be associated with a greater risk of irritation or injury of the occipital nerves; however, the clinical relevance should be confirmed in further studies.
Our research presents limitations associated with its retrospective, single-center study design. Some patients had very long symptom durations and were in advanced stages of the disease before surgery. This may have influenced the clinical and radiological outcomes30. We are also aware that larger groups of patients have been published but most of these were children or children and adults together28. On the other hand, we had an opportunity to analyze and compare the results of 4 different duraplasty patterns applied on a homogenous cohort of patients for age, type of Chiari malformation, and the main principles of surgery technique for one center. To the best of our knowledge, the method of graft fixation in decompression surgery for CM-I has not been analyzed before. However, the relatively limited number of patients, particularly in the AutoG+G group with only 3 patients, did not allowed for firm conclusions. Besides, in the literature, a wide disparity of pseudomeningocele rate is published. Pseudomeningoceles incidentally recognized on imaging studies are considered by some researchers as asymptomatic findings, and do not, therefore, get reported as complications. Others, including our team, consider it important to also report all asymptomatic pseudomeningoceles31. A meta-analysis with multiple randomized prospective cohort studies would be necessary to draw a robust conclusion32,33. The potential causality needs to be explored further in the future by using the Mendelian Randomization framework or deep learning algorithms34–40.
Conclusion
The occurrence of pseudomeningocele in CM-I decompression surgery was significantly higher when nonautologous grafts were used, regardless of the method of fixation. However, the vast majority of the pseudomeningoceles were asymptomatic, and there were no significant differences in long-term clinical outcomes, effect on syringomyelia or the risk of symptomatic postoperative complications. Thus far, our analysis indicates that autologous and nonautologous dural grafts can be either sutured or fixed with glue with very similar clinical results.
Supplementary Information
Author contributions
Conceptualization: [A.B., P.K.]; Methodology: [A.B., P.K., T.D.]; Formal analysis and investigation: [A.B., M.B.]; Writing—original draft preparation: [A.B.]; Writing—review and editing: [P.K.], Mathematical analysis: [S.K.]; Supervison: [A.M.].
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-021-94179-4.
References
- 1.Koehler PJ. Chiari's description of cerebellar ectopy (1891). With a summary of Cleland's and Arnold's contributions and some early observations on neural-tube defects. J. Neurosurg. 1991;75(5):823–826. doi: 10.3171/jns.1991.75.5.0823. [DOI] [PubMed] [Google Scholar]
- 2.Kahn EN, Muraszko KM, Maher CO. Prevalence of Chiari I malformation and syringomyelia. Neurosurg. Clin. N. Am. 2015;26(4):501–507. doi: 10.1016/j.nec.2015.06.006. [DOI] [PubMed] [Google Scholar]
- 3.Strahle J, Muraszko KM, Kapurch J, Bapuraj JR, Garton HJ, Maher CO. Chiari malformation Type I and syrinx in children undergoing magnetic resonance imaging. J. Neurosurg. Pediatr. 2011;8(2):205–213. doi: 10.3171/2011.5.PEDS1121. [DOI] [PubMed] [Google Scholar]
- 4.Penfield W, Coburn DF. Arnold-Chiari malformation and its operative treatment. Arch. Neurol. Psychiatry. 1938;40(2):328–336. doi: 10.1001/archneurpsyc.1938.02270080112007. [DOI] [Google Scholar]
- 5.Zhao JL, Li MH, Wang CL, Meng W. A systematic review of Chiari I malformation: Techniques and outcomes. World Neurosurg. 2016;88:7–14. doi: 10.1016/j.wneu.2015.11.087. [DOI] [PubMed] [Google Scholar]
- 6.Lam FC, Kasper E. Augmented autologous pericranium duraplasty in 100 posterior fossa surgeries—A retrospective case series. Neurosurgery. 2012;71(2 Suppl Operative):ons302–307. doi: 10.1227/NEU.0b013e31826a8ab0. [DOI] [PubMed] [Google Scholar]
- 7.Danish SF, Samdani A, Hanna A, Storm P, Sutton L. Experience with acellular human dura and bovine collagen matrix for duraplasty after posterior fossa decompression for Chiari malformations. J. Neurosurg. 2006;104(1 Suppl):16–20. doi: 10.3171/ped.2006.104.1.16. [DOI] [PubMed] [Google Scholar]
- 8.Narotam PK, Jose S, Nathoo N, Taylon C, Vora Y. Collagen matrix (DuraGen) in dural repair: Analysis of a new modified technique. Spine. 2004;29(24):2861–2867. doi: 10.1097/01.brs.0000148049.69541.ad. [DOI] [PubMed] [Google Scholar]
- 9.Del Gaudio N, Vaz G, Duprez T, Raftopoulos C. Comparison of dural peeling versus duraplasty for surgical treatment of Chiari type I malformation: Results and complications in a monocentric patients' cohort. World Neurosurg. 2018;117:e595–e602. doi: 10.1016/j.wneu.2018.06.093. [DOI] [PubMed] [Google Scholar]
- 10.Abla AA, Link T, Fusco D, Wilson DA, Sonntag VK. Comparison of dural grafts in Chiari decompression surgery: Review of the literature. J. Craniovertebr. Junction Spine. 2010;1(1):29–37. doi: 10.4103/0974-8237.65479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kunert P, Janowski M, Zakrzewska A, Marchel A. Comparision of results between two different techniques of cranio-cervical decompression in patients with Chiari I malformation. Neurol. Neurochir. Pol. 2009;43(4):337–345. [PubMed] [Google Scholar]
- 12.Jia C, Li H, Wu J, et al. Comparison decompression by duraplasty or cerebellar tonsillectomy for Chiari malformation-I complicated with syringomyelia. Clin. Neurol. Neurosurg. 2019;176:1–7. doi: 10.1016/j.clineuro.2018.11.008. [DOI] [PubMed] [Google Scholar]
- 13.Aliaga L, Hekman KE, Yassari R, et al. A novel scoring system for assessing Chiari malformation type I treatment outcomes. Neurosurgery. 2012;70(3):656–664. doi: 10.1227/NEU.0b013e31823200a6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Greenberg JK, Milner E, Yarbrough CK, et al. Outcome methods used in clinical studies of Chiari malformation Type I: A systematic review. J. Neurosurg. 2015;122(2):262–272. doi: 10.3171/2014.9.JNS14406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Team RC . A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2018. [Google Scholar]
- 16.Patil, I. (2021). Visualizations with statistical details: The 'ggstatsplot' approach. Journal of Open Source Software, 6(61), 3167, doi:10.21105/joss.03167
- 17.Attenello FJ, McGirt MJ, Garces-Ambrossi GL, Chaichana KL, Carson B, Jallo GI. Suboccipital decompression for Chiari I malformation: Outcome comparison of duraplasty with expanded polytetrafluoroethylene dural substitute versus pericranial autograft. Childs Nerv. Syst. 2009;25(2):183–190. doi: 10.1007/s00381-008-0700-y. [DOI] [PubMed] [Google Scholar]
- 18.Narotam PK, Qiao F, Nathoo N. Collagen matrix duraplasty for posterior fossa surgery: Evaluation of surgical technique in 52 adult patients. Clinical article. J. Neurosurg. 2009;111(2):380–386. doi: 10.3171/2008.10.JNS08993. [DOI] [PubMed] [Google Scholar]
- 19.Lee CK, Mokhtari T, Connolly ID, et al. Comparison of porcine and bovine collagen dural substitutes in posterior fossa decompression for Chiari I malformation in adults. World Neurosurg. 2017;108:33–40. doi: 10.1016/j.wneu.2017.08.061. [DOI] [PubMed] [Google Scholar]
- 20.Vanaclocha V, Saiz-Sapena N. Duraplasty with freeze-dried cadaveric dura versus occipital pericranium for Chiari type I malformation: Comparative study. Acta Neurochir. 1997;139(2):112–119. doi: 10.1007/bf02747190. [DOI] [PubMed] [Google Scholar]
- 21.Hida K, Yamaguchi S, Seki T, et al. Nonsuture dural repair using polyglycolic acid mesh and fibrin glue: Clinical application to spinal surgery. Surg. Neurol. 2006;65(2):136–142. doi: 10.1016/j.surneu.2005.07.059. [DOI] [PubMed] [Google Scholar]
- 22.Lam FC, Penumaka A, Chen CC, Fischer EG, Kasper EM. Fibrin sealant augmentation with autologous pericranium for duraplasty after suboccipital decompression in Chiari 1 patients: A case series. Surg. Neurol. Int. 2013;4:6. doi: 10.4103/2152-7806.106262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Klekamp J. Surgical treatment of Chiari I malformation–analysis of intraoperative findings, complications, and outcome for 371 foramen magnum decompressions. Neurosurgery. 2012;71(2):365–380. doi: 10.1227/NEU.0b013e31825c3426. [DOI] [PubMed] [Google Scholar]
- 24.Arnautovic A, Splavski B, Boop FA, Arnautovic KI. Pediatric and adult Chiari malformation Type I surgical series 1965–2013: A review of demographics, operative treatment, and outcomes. J. Neurosurg. Pediatr. 2015;15(2):161–177. doi: 10.3171/2014.10.PEDS14295. [DOI] [PubMed] [Google Scholar]
- 25.Kemerdere R, Akgun MY, Cetintas SC, Kacira T, Tanriverdi T. Clinical and radiological outcomes of arachnoid-preseving suboccipital decompression for adult Chiari I malformation with and without syringomyelia. Clin. Neurol. Neurosurg. 2020;188:105598. doi: 10.1016/j.clineuro.2019.105598. [DOI] [PubMed] [Google Scholar]
- 26.Tu A, Tamburrini G, Steinbok P. Management of postoperative pseudomeningoceles: An international survey study. Childs Nerv. Syst. 2014;30(11):1791–1801. doi: 10.1007/s00381-014-2501-9. [DOI] [PubMed] [Google Scholar]
- 27.Farber H, McDowell MM, Alhourani A, Agarwal N, Friedlander RM. Duraplasty type as a predictor of meningitis and shunting after Chiari I decompression. World Neurosurg. 2018;118:e778–e783. doi: 10.1016/j.wneu.2018.07.050. [DOI] [PubMed] [Google Scholar]
- 28.Yahanda AT, Adelson PD, Akbari SHA, et al. Dural augmentation approaches and complication rates after posterior fossa decompression for Chiari I malformation and syringomyelia: A Park-Reeves Syringomyelia Research Consortium study. J. Neurosurg. Pediatr. 2021 doi: 10.3171/2020.8.PEDS2087. [DOI] [PubMed] [Google Scholar]
- 29.Stevens EA, Powers AK, Sweasey TA, Tatter SB, Ojemann RG. Simplified harvest of autologous pericranium for duraplasty in Chiari malformation Type I. Technical note. J. Neurosurg. Spine. 2009;11(1):80–83. doi: 10.3171/2009.3.SPINE08196. [DOI] [PubMed] [Google Scholar]
- 30.Dyste GN, Menezes AH, VanGilder JC. Symptomatic Chiari malformations. An analysis of presentation, management, and long-term outcome. J. Neurosurg. 1989;71(2):159–168. doi: 10.3171/jns.1989.71.2.0159. [DOI] [PubMed] [Google Scholar]
- 31.Foreman P, Safavi-Abbasi S, Talley MC, Boeckman L, Mapstone TB. Perioperative outcomes and complications associated with allogeneic duraplasty for the management of Chiari malformations Type I in 48 pediatric patients. J. Neurosurg. Pediatr. 2012;10(2):142–149. doi: 10.3171/2012.5.PEDS11406. [DOI] [PubMed] [Google Scholar]
- 32.Wu Y, Cao H, Baranova A, Huang H, Li S, Cai L, Rao S, Dai M, Xie M, Dou Y, Hao Q, Zhu L, Zhang X, Yao Y, Zhang F, Xu M, Wang Q. Multi-trait analysis for genome-wide association study of five psychiatric disorders. Transl. Psychiatry. 2020;10(1):209. doi: 10.1038/s41398-020-00902-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jiang L, Wang K, Lo K, Zhong Y, Yang A, Fang X, Akezhuoli H, Song Z, Chen L, An P, Xu M, Min J, Wang F. Sex-specific association of circulating ferritin level and risk of type 2 diabetes: A dose-response meta-analysis of prospective studies. J. Clin. Endocrinol. Metab. 2019;104(10):4539–4551. doi: 10.1210/jc.2019-00495. [DOI] [PubMed] [Google Scholar]
- 34.Zhang F, Baranova A, Zhou C, Cao H, Chen J, Zhang X, Xu M. Causal influences of neuroticism on mental health and cardiovascular disease. Hum Genet. 2021 May 11. doi: 10.1007/s00439-021-02288-x. Epub ahead of print. Erratum in: Hum Genet. 2021 Jul 9;: PMID: 33973063. [DOI] [PubMed]
- 35.Zhang F, Rao S, Cao H, Zhang X, Wang Q, Xu Y, Sun J, Wang C, Chen J, Xu X, Zhang N, Tian L, Yuan J, Wang G, Cai L, Xu M, Baranova A. Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder. J Clin Invest. 2021 Apr 27:145942. doi: 10.1172/JCI145942. Epub ahead of print. PMID: 33905376.. [DOI] [PMC free article] [PubMed]
- 36.Wang X, et al. Genetic support of a causal relationship between iron status and type 2 diabetes: A Mendelian randomization study. J. Clin. Endocrinol. Metab. 2021 doi: 10.1210/clinem. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yu H, Pan R, Qi Y, Zheng Z, Li J, Li H, Ying J, Xu M, Duan S. LEPR hypomethylation is significantly associated with gastric cancer in males. Exp. Mol. Pathol. 2020;116:104493. doi: 10.1016/j.yexmp.2020.104493. [DOI] [PubMed] [Google Scholar]
- 38.Chen J, Zhao X, Cui L, He G, Wang X, Wang F, Duan S, He L, Li Q, Yu X, Zhang F, Xu M. Genetic regulatory subnetworks and key regulating genes in rat hippocampus perturbed by prenatal malnutrition: Implications for major brain disorders. Aging. 2020;12(9):8434–8458. doi: 10.18632/aging.103150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Liu M, Li F, Yan H, Wang K, Ma Y, Alzheimer’s Disease Neuroimaging Initiative. Shen L, Xu M. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease. Neuroimage. 2020;208:116459. doi: 10.1016/j.neuroimage.2019.116459. [DOI] [PubMed] [Google Scholar]
- 40.Li H, Wang X, Lu X, Zhu H, Li S, Duan S, Zhao X, Zhang F, Alterovitz G, Wang F, Li Q, Tian XL, Xu M. Co-expression network analysis identified hub genes critical to triglyceride and free fatty acid metabolism as key regulators of age-related vascular dysfunction in mice. Aging. 2019;11(18):7620–7638. doi: 10.18632/aging.102275. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

